Results 71 to 80 of about 502,860 (198)

Review: Practical considerations in ovarian cancer chemotherapy

Therapeutic Advances in Medical Oncology, 2010
Epithelial ovarian cancer remains the most lethal gynecologic malignancy despite advances in treatment. The standard management generally involves a combination of surgical tumor debulking and chemotherapy.
Mihaela Cristea MD, Ernest Han, Lennie Salmon, Robert J. Morgan   +3 more
doaj   +1 more source

Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]

, 2014
The role of systemic chemotherapy (SC) in conjunction with cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in appendiceal mucinous carcinoma peritonei (MCP) is ...
Blackham, Aaron U., Eng, Cathy, Bergman, Simon, Votanopoulos, Konstantinos, Konstantinos Votanopoulos, Levine, Edward A., Edward A. Levine, Geisinger, Kim R, Kim R Geisinger, Stewart, John H., Simon Bergman, Katrina Swett, Shen, Perry, Joseph Sirintrapun, Swett, Katrina, Cathy Eng, Aaron U. Blackham, Sirintrapun, Joseph, Perry Shen, John H. Stewart   +19 more
core   +1 more source

Intraperitoneal vs. systemic chemotherapy in ovarian cancer [PDF]

, 2018
Od ponad 20 lat chemioterapia dootrzewnowa (intraperitoneal therapy, IP) stosowana jest w przypadku raka jajnika. Główna strategia tej metody polega na uzyskaniu wyższego lokalnego stężenia cytostatyku w jamie otrzewnej i wydłużonej ekspozycji tkanek na ...
Markowska, Janina
core  

Intraperitoneal chemotherapy for ovarian cancer [PDF]

, 2009
The paper is a detailed review of recent advances in the treatment of ovarian cancer patients using intraperitoneal chemotherapy. Theoretical basis of intraperitoneal treatment is discussed, this being understood as passage of substances through ...
Milczek, Tomasz, Klasa-Mazurkiewicz, Dagmara, Emerich, Janusz   +2 more
core  

PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

, 2018
BACKGROUND: Recurrent, platin-resistant ovarian cancer (rPROC) has a poor survival. Even with the AURELIA trial, which is the best available treatment today, progression-free survival (PFS) is still only 6.7 months from the start of the second-line ...
Scambia, Giovanni
core   +1 more source

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

Asian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong, Yu-Qiang Shan, Wen-Cheng Kong, Hao-Ran Wei, Lin-Po Zhou, Ye-Bin Yang, Jing Shi, Cheng-Hao Ji, Yi-Jia Zhang   +8 more
doaj   +1 more source

Intraperitoneal chemotherapy for peritoneal metastases of gastric origin:a systematic review and meta-analysis [PDF]

Background: Gastric cancer with peritoneal metastases is associated with a dismal prognosis. Normothermic catheter-based intraperitoneal chemotherapy and normothermic pressurized intraperitoneal aerosol chemotherapy (PIPAC) are methods to deliver ...
Noordman, Bo J., Koolen, Stijn L.W., Guchelaar, Niels A.D., Wijnhoven, Bas P.L., Lagarde, Sjoerd M., Nasserinejad, Kazem, Mathijssen, Ron H.J.; id_orcid, Mostert, Bianca, Van Der Sluis, Pieter C.   +8 more
core   +1 more source

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

Current Oncology
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different ...
Miklos Acs, Pompiliu Piso, Gabriel Glockzin   +2 more
doaj   +1 more source

Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

, 2017
Background: Incisional hernia formation has been reported as high as 20% within 1 year following midline laparotomy. Since hyperthermic intraperitoneal chemotherapy is likely to impair wound healing, we sought to investigate the incidence of incisional ...
F. Struller, P. Horvath, I. Koenigsrainer, A. Koenigsrainer, S. Beckert   +4 more
core   +1 more source

Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study

Annals of Gastroenterological Surgery
Background The effectiveness of intraperitoneal chemotherapy using paclitaxel (i.p.‐PTX) in pancreatic ductal adenocarcinoma (PDAC) patients with peritoneal dissemination remains elusive.
Tomohisa Yamamoto, Toshio Shimokawa, Masamichi Hayashi, Masamichi Mizuma, Katsuhisa Hirano, Atsushi Oba, Toshimichi Asano, Hideyo Miyato, Makoto Yoshida, Ippei Matsumoto, Yasunari Kawabata, Katsunori Sakamoto, Fuyuhiko Motoi, Shigeto Ishii, Yuki Homma, Hiromitsu Maehira, Yutaro Matsunaga, Tetsuya Ikemoto, Masafumi Nakamura, Yuko Mataki, Tsuyoshi Notake, Keiichi Akahoshi, Hideki Takami, So Yamaki, Daisuke Hashimoto, Yasutoshi Kimura, Satoshi Hirano, Yosuke Inoue, Tsutomu Fujii, Michiaki Unno, Yasuhiro Kodera, Joji Kitayama, Sohei Satoi, the Study Group of Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination   +33 more
doaj   +1 more source